Since their first description by Sophie Spitz, Spitz nevi have been a subject of controversy among clinicians for many decades, and remain a clinical conundrum until today as their etiology, morphology, biological behavior and natural evolution is still not totally clear. This is because their clinical, dermoscopic and histopathologic features sometimes overlap with those of melanoma, rendering the management of spitzoid lesions particularly difficult. In addition, cases of histopatologically equivocal lesions do exist and their classification might sometimes be very challenging. Among several terms that have been used to describe these morphologically "intermediate" lesions, atypical Spitz tumor (AST) is the most widely used. The aim of this review paper was to describe the dermoscopic patterns and structures seen in Spitz/Reed nevi, spitzoid melanoma and AST. Finally, this article provides an evidence-based update on the available options for the management of spitzoid lesions, before and after histopathologic diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.19.06294-1DOI Listing

Publication Analysis

Top Keywords

management spitzoid
8
spitzoid lesions
8
dermoscopy spitz/reed
4
spitz/reed naevi
4
naevi management
4
management description
4
description sophie
4
sophie spitz
4
spitz spitz
4
spitz nevi
4

Similar Publications

Background: Melanoma is the most malignant skin tumor, with a high metastatic potential. Spitzoid melanoma is a subtype of melanoma requiring rapid management and extensive tumor resection. We have set the goal to recognize anatomical peculiarities and difficulties diagnoses posed by this type of tumor, as well as to recognize the management modalities, especially the surgical one, of malignant spitzoid melanoma.

View Article and Find Full Text PDF

Clinical features and outcomes of paediatric Spitz-type lesions.

J Plast Reconstr Aesthet Surg

October 2024

Plastic Surgery Unit, Addenbrooke's Hospital, Hills Rd, Cambridge, UK.

Article Synopsis
  • Some doctors in the UK are careful about treating Spitz-type lesions in kids, often suggesting they should be removed to be safe.
  • Researchers studied 91 kids with these lesions and found that most had harmless forms, and many did not need ongoing check-ups after treatment.
  • The study showed that these lesions are usually not harmful, so doctors don't think aggressive treatments are needed for most kids with these skin spots.
View Article and Find Full Text PDF

Melanoma in Pediatric and Young Adult Patients.

Curr Oncol Rep

July 2024

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, U.S.A.

Article Synopsis
  • Melanoma presents differently in younger patients compared to older individuals, with unique clinical features and prognosis that warrant specific attention.
  • Recent advancements in molecular techniques help distinguish between true melanoma and atypical lesions like Spitz tumors, improving the accuracy of diagnosis in younger populations.
  • While the treatment for confirmed melanoma in young individuals is similar to that in older patients, optimal strategies for atypical Spitz tumors remain unclear, emphasizing the need for better understanding and awareness for earlier detection and effective management.
View Article and Find Full Text PDF

A Comparative Demographic Study of Atypical Spitz Nevi and Malignant Melanoma.

Acta Dermatovenerol Croat

December 2023

Martina Lambertini, MD, Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Massarenti 1, 40100 Bologna, Italy;

Article Synopsis
  • - Spitz tumors are a type of skin growth that includes both benign and malignant forms, specifically ranging from Spitz nevus (benign) to Spitzoid melanoma (malignant and potentially deadly), with ongoing debates about their classification.
  • - Atypical Spitz tumors (ASTs) share characteristics with benign Spitz nevi but also show some signs of cancer, complicating diagnosis, which primarily relies on histopathology despite ongoing challenges in distinguishing between benign and malignant cases.
  • - The study involved analyzing patient data from two Italian dermatology centers over a decade to compare ASTs and malignant melanomas (MMs), utilizing statistical methods to evaluate differences in demographic and clinical factors, including age, sex, and the body site of
View Article and Find Full Text PDF

Preferentially Expressed Antigen in Melanoma (PRAME), a member of the cancer/testis antigen family, is central to the field of skin cancer diagnostics and therapeutics. As a nuclear receptor and transcriptional regulator, PRAME plays a critical role in inhibiting retinoic acid signalling, which is essential for cell differentiation and proliferation. Its aberrant overexpression in various malignancies, particularly cutaneous melanoma, is associated with more aggressive tumour phenotypes, positioning PRAME as both a diagnostic and prognostic marker.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!